Alexandra Voutsina

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki et al. · British Journal of Cancer · 2008 · 207 citations · Full text

Medicine, Oncology, Pharmacology +16

<i>ESR1</i> Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

Αreti Strati, Eleni Tzanikou, Maria Chimonidou et al. · Clinical Cancer Research · 2017 · 154 citations

Medicine, Molecular Medicine, Oncology +17

DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non–Small-Cell Lung Cancer

Aristea Kalikaki, Maria Kanaki, Helen Vassalou et al. · Clinical Lung Cancer · 2009 · 150 citations

Medicine, Genetics, Oncology +10

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

Athanasios Karampeazis, Alexandra Voutsina, John Souglakos et al. · Cancer · 2013 · 112 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

Athanasios Pallis, Alexandra Voutsina, Ar Kalikaki et al. · British Journal of Cancer · 2007 · 92 citations · Full text

Medicine, Molecular Genetics, Oncology +17